offline
Healthcare | Biotechnology | USA
Akari Therapeutics' stock rockets on massive volume after 'successful' pre-IND FDA meeting
Shares of Akari Therapeutics PLC AKTX, more than doubled--soaring 145%--toward a 15-month high in very active morning trade Wednesday, enough to pace all the gainers on the Nasdaq exchange, after the company said it plans to commence trials in European and U.S. pediatric patients this year for its treatment of pediatric thrombotic microangiopathy. Trading volume rocketed to 22.3 million shares, compared with the full-day average of about 20,000 shares.
...
https://www.marketwatch.com/story/akari-...yptr=yahoo
![[Bild: AKTXc1dl1712.png]](https://finviz.com/publish/031319/AKTXc1dl1712.png)
Akari Therapeutics' stock rockets on massive volume after 'successful' pre-IND FDA meeting
Shares of Akari Therapeutics PLC AKTX, more than doubled--soaring 145%--toward a 15-month high in very active morning trade Wednesday, enough to pace all the gainers on the Nasdaq exchange, after the company said it plans to commence trials in European and U.S. pediatric patients this year for its treatment of pediatric thrombotic microangiopathy. Trading volume rocketed to 22.3 million shares, compared with the full-day average of about 20,000 shares.
...
https://www.marketwatch.com/story/akari-...yptr=yahoo
